Agreement of dermatopathologists in the evaluation of clinically difficult melanocytic lesions: How golden is the 'gold standard'?

Dermatology

Volumn 224, Issue 1, 2012, Pages 51-58

  Braun, R P ^a   Gutkowicz Krusin, D ^b   Rabinovitz, H ^c   Cognetta, A ^d   Hofmann Wellenhof, R ^j   Ahlgrimm Siess, V ^j   Polsky, D ^e   Oliviero, M ^c   Kolm, I ^a   Googe, P ^g   King, R ^g   Prieto, V G ^h   French, L ^a   Marghoob, A ^f   Mihm, M ⁱ  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b MELA Sciences Inc   (United States)

^c SKIN AND CANCER ASSOCIATES   (United States)

^d Dermatology Associates of Tallahassee   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g Knoxville Dermatopathology Laboratory   (United States)

^h UNIVERSITY OF TEXAS   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j Universitatsklinik fur Dermatologie und Venerologie   (Austria)

more..

Author keywords

Agreement; Dermoscopy; Diagnosis; Histopathology; Melanoma

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATYPICAL MOLE SYNDROME; CANCER DIAGNOSIS; CHILD; DATA BASE; FEMALE; HISTOPATHOLOGY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MELANOCYTOSIS; MELANOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SKIN BIOPSY; SKIN DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFANT; MALE; MELANOMA; MIDDLE AGED; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SKIN NEOPLASMS; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84861099702     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000336886     Document Type: Article

References (35)

1. Thompson B, Austin R, Coory M, Aitken JF, Walpole E, Francis G, Fritschi L: Completeness of histopathology reporting of melanoma in a high-incidence geographical region. Dermatology 2009; 218: 7-14.
2. Mayer J: Systematic review of the diagnostic accuracy of dermatoscopy in detecting malignant melanoma. Med J Aust 1997; 167: 206-210.
3. Lock-Andersen J, Hou-Jensen K, Hansen J, Jensen N, Sogaard H, Andersen P: Observer variation in histological classification of cutaneous malignant melanoma. Scand J Plast Reconstr Surg Hand Surg 1995; 29: 141-148.
4. Busam K, Antonescu C, Marghoob M, Nehal K, Sachs D, Shia J, Berwick M: Histologic classification of tumor-infiltrating lymphocytes in primary cutaneous malignant melanoma. A study of interobserver agreement. Am J Clin Pathol 2001; 115: 856-860.
5. Oliveria S, Dusza S, Berwick M: Issues in the epidemiology of melanoma. Expert Rev Anticancer Ther 2001; 1: 453-459.
6. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB: Evidence-Based Medicine: How to Practice and Teach EBM. Edinburgh/New York, Churchill Livingstone, 2000.
7. Kittler H, Pehamberger H, Wolff K, Binder M: Diagnostic accuracy of dermoscopy. Lancet Oncol 2002; 3: 159-165.
8. Vestergaard M, Macaskill P, Holt P, Menzies SW: Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: A meta-analysis of studies performed in a clinical setting. Br J Dermatol 2008; 159: 669-676.
9. Elbaum M, Kopf AW, Rabinovitz HS, et al: Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: A feasibility study. J Am Acad Dermatol 2001; 44: 207-218.
10. Friedman RJ, Gutkowicz-Krusin D, Farber MJ, et al: The diagnostic performance of expert dermoscopists vs a computer-vision system on small-diameter melanomas. Arch Dermatol 2008; 144: 476-482.
11. Monheit G, Cognetta AB, Ferris L, et al: The performance of MelaFind: A prospective multicenter study. Arch Dermatol 2011; 147: 188-194.
12. Fleiss JL: Statistical Methods for Rates and Proportions. New York, John Wiley, 1981.
13. Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
14. Uebersax JS: Diversity of decision-making models and the measurement of interrater agreement. Psychol Bull 1987; 101: 140-146.
15. Uebersax JS: Modeling approaches for the analysis of observer agreement. Invest Radiol 1992; 27: 738-743.
16. Kundel HL, Polansky M: Measurement of observer agreement. Radiology 2003; 228: 303-308.
17. Fisher LD: Biostatistics. New York, Wiley, 1993.
18. Marghoob AA, Kopf AW, Rigel DS, et al: Risk of cutaneous malignant melanoma in patients with 'classic' atypical-mole syndrome. A case-control study. Arch Dermatol 1994; 130: 993-998.
19. Kopf AW, Friedman RJ, Rigel DS: Atypical mole syndrome. J Am Acad Dermatol 1990; 22: 117-118.
20. Cuellar F, Puig S, Kolm I, Puig-Butille S, Zaballos P, Marti-Laborda R, Badenas C, Malvehy J: Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers. Br J Dermatol 2009; 160: 48-53.
21. Shoo BA, Sagebiel RW, Kashani-Sabet M: Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center. J Am Acad Dermatol 2010; 62: 751-756.
22. Farmer ER, Gonin R, Hanna MP: Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 1996; 27: 528-531.
23. Duncan L, Berwick M, Bruijn J, Byers H, Mihm M, Barnhill R: Histopathologic recognition and grading of dysplastic melanocytic nevi: An interobserver agreement study. J Invest Dermatol 1993; 100: 318S-321S.
24. Corona R, Mele A, Amini M, et al: Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol 1996; 14: 1218-1223.
25. Cook M, Clarke T, Humphreys S, et al: The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel. Histopathology 1996; 28: 497-512.
26. Ferrara G, Argenziano G, Soyer HP, et al: Dermoscopic and histopathologic diagnosis of equivocal melanocytic skin lesions: An interdisciplinary study on 107 cases. Cancer 2002; 95: 1094-1100.
27. Ferrara G, Argenziano G, Soyer HP, et al: Histopathologic interobserver agreement on the diagnosis of melanocytic skin lesions with equivocal dermoscopic features: A pilot study. Tumori 2000; 86: 445-449.
28. Zembowicz A, Scolyer RA: Nevus/melanocytoma/melanoma: An emerging paradigm for classification of melanocytic neoplasms? Arch Pathol Lab Med 2011; 135: 300-306.
29. Grichnik J: Melanoma, nevogenesis, and stem cell biology. J Invest Dermatol 2008; 128: 2365-2380.
30. Zalaudek I, Hofmann-Wellenhof R, Soyer HP, Ferrara G, Argenziano G: Naevogenesis: New thoughts based on dermoscopy. Br J Dermatol 2006; 154: 793-794.
31. Zalaudek I, Ferrara G, Argenziano G: Dermoscopy insights into nevogenesis: 'Abtropfung' versus 'Hochsteigerung'. Arch Dermatol 2007; 143: 284.
32. Zalaudek I, Marghoob AA, Scope A, Hofmann-Wellenhof R, Ferrara G, Argenziano G: Age distribution of biopsied junctional nevi - Unna's concept versus a dual concept of nevogenesis. J Am Acad Dermatol 2007; 57: 1096-1097.
33. Zalaudek I, Hofmann-Wellenhof R, Kittler H, et al: A dual concept of nevogenesis: Theoretical considerations based on dermoscopic features of melanocytic nevi. J Dtsch Dermatol Ges 2007; 5: 985-992.
34. Aguilera P, Puig S: Clinical and dermoscopic features of nevi in children. Dermatology 2010;220:54.
35. Barnhill RL: Melanocytic nevi and tumor progression: Perspectives concerning histomorphology, melanoma risk and molecular genetics. Dermatology 1993; 187: 86-90.